Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) For research use only.
Not for use in humans.

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: BI-754091

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.48 KD.

Ezabenlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. It can be used in the treatment of advanced solid tumors. MW :145.48 KD.

Product Details

CAS No. 2249882-54-8
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) cost | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) | Ezabenlimab (Anti-PDCD1 / PD-1 / CD279) distributor